Tamai Y, Torihara M, Kido Y, Yamahara J, Motizuki M, Ito M, Katsuta Y
Kuraray Co., Ltd., Nakajhochou Niigata, Japan.
Yakugaku Zasshi. 1993 Sep;113(9):655-62. doi: 10.1248/yakushi1947.113.9_655.
gamma-Hydroxybutenolides possessing conjugated substituents at the beta-position and their related compounds have been synthesized by the previously reported procedure with minor modifications and their antiulcer activities have been examined in the HCl-ethanol induced ulcer model often used for the evaluation of gastric mucosal protective factor enhancing effect. The compound A-1 5-hydroxy-4-[2-(2,6,6-trimethyl-1-cycohexenyl-1-yl)-(E)-ethenyl]-2 (5H)-furanone showed a pronounced effect at a low dosage of 5 mg/kg p.o. and some analogues compounds also exhibited potent inhibitory activity as compared with the reference drugs. The relationship between the structure of gamma-hydroxybutenolides and the antiulcer effect has been also examined and then the 5-hydroxyl group has been found to be essentially functional one to have antiulcer activity.
在β位带有共轭取代基的γ-羟基丁烯内酯及其相关化合物已通过先前报道的方法并稍作修改进行合成,并在常用于评估胃黏膜保护因子增强作用的盐酸-乙醇诱导溃疡模型中检测了它们的抗溃疡活性。化合物A-1(5-羟基-4-[2-(2,6,6-三甲基-1-环己烯-1-基)-(E)-乙烯基]-2(5H)-呋喃酮)在口服剂量低至5mg/kg时显示出显著效果,与参比药物相比,一些类似化合物也表现出强效抑制活性。还研究了γ-羟基丁烯内酯的结构与抗溃疡作用之间的关系,结果发现5-羟基是具有抗溃疡活性的基本官能团。